OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
104 hedge funds and large institutions have $55.3M invested in Orexigen Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 34 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
68% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 25
Holders
104
Holding in Top 10
1
Calls
$162K
Puts
$366K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$876K | |
| 3 | +$442K | |
| 4 |
DY
Dowling & Yahnke
San Diego,
California
|
+$385K |
| 5 |
Renaissance Technologies
New York
|
+$346K |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$2.36M | |
| 3 | -$1.93M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.36M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$1.01M |